Management of Patients with High-Grade Glioma - European Medical Journal

Management of Patients with High-Grade Glioma

Download PDF
Simge Yuksel,1 Anna Kolb,2 Ihsan Solaroglu,3 *Colin Watts2

No potential conflict of interest.

EMJ Oncol. ;2[1]:91-99. DOI/10.33590/emjoncol/10312293.
High-grade glioma, surgery, adjuvant therapy, prognosis.

Each article is made available under the terms of the Creative Commons Attribution-Non Commercial 4.0 License.


The scientific basis for the surgical management of patients with glioma is rapidly evolving. The infiltrative nature of these cancers precludes a surgical cure, but despite this, cytoreductive surgery remains central to high-quality patient’s care. In addition to tissue sampling for accurate histopathological diagnosis and molecular genetic characterisation, clinical benefit from decompression of space-occupying lesions and microsurgical cytoreduction has been reported in patients with different grades of glioma. By integrating advanced surgical techniques with molecular genetic characterisation of the disease and targeted radiotherapy and chemotherapy, it is possible to construct a programme of personalised surgical therapy throughout the patient’s journey. The goal of therapeutic packages tailored to each patient is to optimise patient safety and clinical outcome, and must be delivered in a multidisciplinary setting. Here we review the current concepts that underlie surgical management of patients with high-grade glioma.

Please view the full content in the pdf above.

Join our mailing list

To receive the EMJ updates straight to your inbox free of charge, please click the button below.
Join Now